New insights into causes of loss of orientation in dementia

by University of ExeterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.New research has revealed how disease-associated changes in two interlinked n

Updated on: February 27,2024

New insights into causes of loss of orientation in dementia

by University of ExeterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.New research has revealed how disease-associated changes in two interlinked n

Updated on:February 27,2024

New clues to early development of schizophrenia

byElsevierDerivation and characterization of hCSs. (A) Experimental design of the study. (B) Main growth factors and media used for neural induction and differentiation. DM and SB are SMAD inhib

Updated on: January 12,2024

New clues to early development of schizophrenia

byElsevierDerivation and characterization of hCSs. (A) Experimental design of the study. (B) Main growth factors and media used for neural induction and differentiation. DM and SB are SMAD inhib

Updated on:January 12,2024

Socially active 60-year-olds face lower dementia risk

by University College LondonCredit: CC0 Public DomainBeing more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study.Thelongi

Updated on: June 14,2024

Socially active 60-year-olds face lower dementia risk

by University College LondonCredit: CC0 Public DomainBeing more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study.Thelongi

Updated on:June 14,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024

5α-reductase inhibitors linked to depression, but not dementia

by Elana Gotkine HealthDay Reporter5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published onl

Updated on: March 13,2024

5α-reductase inhibitors linked to depression, but not dementia

by Elana Gotkine HealthDay Reporter5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published onl

Updated on:March 13,2024

How blocking a neural receptor responsible for addiction could reduce alcohol use

by The Scripps Research InstituteTime course of alcohol self-administration acquisition across 21 training sessions and escalation of drinking during week 6 of CIE vapor exposure. (A) Male and fe

Updated on: March 30,2024

How blocking a neural receptor responsible for addiction could reduce alcohol use

by The Scripps Research InstituteTime course of alcohol self-administration acquisition across 21 training sessions and escalation of drinking during week 6 of CIE vapor exposure. (A) Male and fe

Updated on:March 30,2024

How retrotransposons control the brain

by John Hewitt , Medical XpressCredit: WikipediaAround half of the genome is made up of transposable elements or 'jumping genes' that derive from ancient viral integrations. They persist in va

Updated on: June 01,2024

How retrotransposons control the brain

by John Hewitt , Medical XpressCredit: WikipediaAround half of the genome is made up of transposable elements or 'jumping genes' that derive from ancient viral integrations. They persist in va

Updated on:June 01,2024

The brain pulsates differently in people suffering from Alzheimer's disease

by University of OuluIn the magnetic resonance image, a healthy brain is higher and a lower one with Alzheimer's disease. Pulsations in the brain appear as red signals at the frequency of the hear

Updated on: April 20,2024

The brain pulsates differently in people suffering from Alzheimer's disease

by University of OuluIn the magnetic resonance image, a healthy brain is higher and a lower one with Alzheimer's disease. Pulsations in the brain appear as red signals at the frequency of the hear

Updated on:April 20,2024

Alzheimer's leads to changes in the small blood vessels in the brain

by University of OsloEarlier research has shown that several of the same risk factors behind the development of cardiovascular disease also can lead to Alzheimer’s. Pictured left to right: Shreya

Updated on: April 25,2024

Alzheimer's leads to changes in the small blood vessels in the brain

by University of OsloEarlier research has shown that several of the same risk factors behind the development of cardiovascular disease also can lead to Alzheimer’s. Pictured left to right: Shreya

Updated on:April 25,2024

Research suggests myelin fatty acid metabolism could serve as an energy reserve for the central nervous system

by Ingrid Fadelli , Medical XpressElectron microscopy image of optic nerve myelin. Credit: Wiebke Moebius, MPI Goettingen.The brains of mammals expend a significant amount of energy in the form of ade

Updated on: October 18,2024

Research suggests myelin fatty acid metabolism could serve as an energy reserve for the central nervous system

by Ingrid Fadelli , Medical XpressElectron microscopy image of optic nerve myelin. Credit: Wiebke Moebius, MPI Goettingen.The brains of mammals expend a significant amount of energy in the form of ade

Updated on:October 18,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

ssResearchers identify key steps to toxic protein accumulation in Alzheimer's and other diseases

by Tamara Bhandari,Washington University School of Medicine in St. LouisStress granules (red) fill stem cell-derived neurons (nuclei shown in blue) from a person with a mutation in the tau gene.

Updated on: March 02,2024

ssResearchers identify key steps to toxic protein accumulation in Alzheimer's and other diseases

by Tamara Bhandari,Washington University School of Medicine in St. LouisStress granules (red) fill stem cell-derived neurons (nuclei shown in blue) from a person with a mutation in the tau gene.

Updated on:March 02,2024